Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yifei Qinghua granule
- Development stage
- Unknown
- Lead developer
- Henan University of Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Yifei Qinghua granule is a Traditional Chinese Medicine (TCM) herbal formulation developed for the treatment of respiratory diseases, including clinically stable bronchiectasis and advanced lung cancer. Originally developed under the name Feiliuping during China's national research projects, it was later renamed upon approval for listing. The formulation consists of a complex mixture of herbs including Astragalus, Codonopsis, Glehnia littoralis, Ophiopogon, Agrimonia, Patriniaceae, Oldenlandia diffusa, Fritillaria, Aster, Platycodon, bitter almond, and licorice. In clinical practice, it is specifically indicated for patients presenting with the TCM syndrome of 'Qi and Yin deficiency of the lung and phlegm-heat obstructing the lung.' Research indicates that its therapeutic activity may be related to the modulation of vascular endothelial growth factor (VEGF) and various inflammatory pathways.
- Brand names
- Yifei Qinghua granule
- Other names
- FeiliupingYifei Qinghua
02
Targets
Beyond the preview
Go deeper on Yifei Qinghua granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yifei Qinghua granule.